Abstract: An optical lens assembly includes, in order from an object side to an image side: a stop, a first lens, a second lens, a third lens, a fourth lens, and fifth lens, wherein an Abbe number of the second lens is vd2, an Abbe number of the third lens is vd3, a central thickness of the second lens along the optical axis is CT2, a central thickness of the third lens along the optical axis is CT3, the aperture number of the optical lens assembly is Fno, an incident angle of a main light incident at the position of 60% of the maximum image height of the optical lens assembly is CRA6, and the following conditions are satisfied: 3.54<(vd3*CT3?vd2*CT2)/Fno<8.18 and 28.25<CRA6<35.76.

Abstract: An actuating and sensing module is disclosed and includes a bottom plate, a gas pressure sensor, a thin gas transportation device and a cover plate. The bottom plate includes a pressure relief orifice, a discharging orifice and a communication orifice. The gas pressure sensor is disposed on the bottom plate and seals the communication orifice. The thin gas transportation device is disposed on the bottom plate and seals the pressure relief orifice and the discharging orifice. The cover plate is disposed on the bottom plate and covers the gas pressure sensor and the thin gas-transportation device. The cover plate includes an intake orifice. The thin gas transportation device is driven to inhale gas through the intake orifice, the gas is then discharged through the discharging orifice by the thin gas transportation device, and a pressure change of the gas is sensed by the gas pressure sensor.

Abstract: The present invention provides a lactic acid bacteria composition, which comprises: a Lactobacillus plantarum PL-02 strain, a Lactobacillus acidophilusTYCA06 strain, a Lactobacillus casei CS-773 strain, and a physiologically acceptable excipient, diluent, or carrier. All of the strains are deposited at the China General Microbiological Culture Collection Center.

Abstract: Disclosed herein is a composition including Lactobacillus plantarum TWK10 deposited at the China General Microbiological Culture Collection Center (CGMCC) under accession number CGMCC 13008 for use in treating sarcopenia and for use in maintaining and/or increasing muscle mass and/or strength in an elderly subject.

Abstract: The present invention provides a lactic acid bacteria composition, which comprises: a Lactobacillus plantarum PL-02 strain, a Lactobacillus acidophilusTYCA06 strain, a Lactobacillus casei CS-773 strain, and a physiologically acceptable excipient, diluent, or carrier.

Abstract: Disclosed herein is a composition including Lactobacillus plantarum TWK10 deposited at the China General Microbiological Culture Collection Center (CGMCC) under accession number CGMCC 13008 for use in improving walking capacity of an elderly subject.

Abstract: An isolated lactic acid bacteria strain: Bifidobacterium longum subsp. longum OLP-01 strain for increasing exercise performance and ameliorating fatigue is disclosed. A variety of animal experiments have proved that OLP-01 not only effectively improves muscle strength and swimming endurance but also significantly reduces fatigue-related biochemical indicators, including blood lactate, blood urea nitrogen and the activity of creatine kinase.

Abstract: Disclosed herein is a composition including Lactobacillus plantarum TWK10 deposited at the China General Microbiological Culture Collection Center (CGMCC) under accession number CGMCC 13008 for use in treating sarcopenia and for use in maintaining and/or increasing muscle mass and/or strength in an elderly subject.

Abstract: An isolated lactic acid bacteria strain: Bifidobacterium longum subsp. longum OLP-01 strain for increasing exercise performance and ameliorating fatigue is disclosed. A variety of animal experiments have proved that OLP-01 not only effectively improves muscle strength and swimming endurance but also significantly reduces fatigue-related biochemical indicators, including blood lactate, blood urea nitrogen and the activity of creatine kinase.

Abstract: The present invention is directed to a use of Lactobacillus plantarum LP10 for reducing body fat, controlling obesity or overweight, and alleviating an obesity-related disease caused by excessively high body fat. The Lactobacillus plantarum LP10 is deposited in China General Microbiological Culture Collection Center (CGMCC), the accession number is CGMCC 13008.

Abstract: The invention provides a method which comprises administering an effective amount of a probiotic composition including Lactobacillus plantarum TWK10 for improving inflammation after exercise. The Lactobacillus plantarum TWK10 is deposited in Taiwan Food Industry Research and Development Institute (FIRDI) with the accession number BCRC910734, and in China General Microbiological Culture Collection Center (CGMCC) with the accession number CGMCC 13008.

Abstract: Disclosed herein are a starter culture and a fermented product prepared using such starter culture. The starter culture comprises a mixture of Lactobacillus fermentum strain LF26, Lactobacillus helveticus strain LH43, Lactobacillus paracasei strain LPC12, Lactobacillus rhamnosus strain LRH10, and Streptococcus thermophilus strain ST30. Also disclosed herein are methods for reducing fatigue, improving exercise performance, and/or modifying gut microbiota. Each of these methods includes administering to a subject the fermented product.

Abstract: The present invention is directed to a use of Lactobacillus plantarum LP10 for reducing body fat, controlling obesity or overweight, and alleviating an obesity-related disease caused by excessively high body fat. The Lactobacillus plantarum LP10 is deposited in China General Microbiological Culture Collection Center (CGMCC), the accession number is CGMCC 13008.

Abstract: The present invention is directed to a use of anti-fatigue probiotic bacteria for improving exercise performance, particularly the fatigue caused by exercise. The anti-fatigue probiotic bacteria increases muscle mass and endurance, decreases blood lactate, ammonia, and creatine kinase concentration, and changes body composition; the said bacteria can be used to improve exercise performance.

Abstract: The present invention is directed to a use of anti-fatigue probiotic bacteria for improving exercise performance, particularly the fatigue caused by exercise. The anti-fatigue probiotic bacteria increases muscle mass and endurance, decreases blood lactate, ammonia, and creatine kinase concentration, and changes body composition; the said bacteria can be used to improve exercise performance.

Abstract: Disclosed are extracts, compositions, and methods for treating cancer and inflammatory disorders. Also disclosed are methods for preparing extracts or compounds for treating the disorders.

Abstract: Disclosed are extracts, compositions, and methods for treating cancer and inflammatory disorders. Also disclosed are methods for preparing extracts or compounds for treating the disorders.

Abstract: Disclosed are extracts, compositions, and methods for treating cancer and inflammatory disorders. Also disclosed are methods for preparing extracts or compounds for treating the disorders.

Abstract: Disclosed are extracts, compositions, and methods for treating cancer and inflammatory disorders. Also disclosed are methods for preparing extracts or compounds for treating the disorders.